Page last updated: 2024-08-24

1,2-dipalmitoyl-3-phosphatidylethanolamine and Brain Neoplasms

1,2-dipalmitoyl-3-phosphatidylethanolamine has been researched along with Brain Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cossu, F; Melis, G; Rombi, G1

Other Studies

1 other study(ies) available for 1,2-dipalmitoyl-3-phosphatidylethanolamine and Brain Neoplasms

ArticleYear
mAb-labeled liposomes in breast cancer cell targeting. Therapeutics and diagnostic use of polyspecific artificial carriers.
    Annals of the New York Academy of Sciences, 1993, Nov-30, Volume: 698

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Antibodies, Monoclonal; Brain Neoplasms; Breast Neoplasms; Drug Carriers; Female; Humans; Iodine Radioisotopes; Liposomes; Liver Neoplasms; Neoplasm Metastasis; Phosphatidylethanolamines; Radioimmunodetection; Technetium

1993